Geron Stock Price. Everything You Need To Know About The Geron Stock!
Geron Corp. operates as a biotechnology company. The company is headquartered in Foster City, California and currently employs 107 full-time employees. The firm is focused on the development and commercialization of imetelstat, a therapeutic for hematologic malignancies. The firm operates through a single segment, which is engaged in the development of therapeutic products for oncology. Imetelstat is a lipid conjugated 13mer oligonucleotide that the Company designed to be complementary to and bind with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity. Its lead indication for imetelstat is in low or intermediate-1 risk myelodysplastic syndromes (MDS). The company is also engaged in the development of two indications, such as the treatment of adult patients with transfusion-dependent anemia due to lower risk MDS, and the treatment of adult patients with Intermediate-2 or High-Risk MF whose disease has relapsed after or is refractory to janus associate kinase inhibitor (JAK) inhibitor treatment.
Geron Stock Price. Everything You Need To Know About The Geron Stock! performance
- Employees 107
- Company HQ Foster City
- Website https://www.geron.com/
- GERN Asset Type Common Stock
- GERN Market Capitalization 2.4B
- Earnings Per Share -0.32
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Geron is a prominent biopharmaceutical company specializing in the development of innovative therapies for the treatment of cancer. With its cutting-edge research and impressive pipeline of potential breakthrough drugs, investors from Malaysia, Thailand, Indonesia, and Vietnam have a unique opportunity to invest in this promising stock. But how can retail investors in these countries access this lucrative opportunity? Thanks to Zorion, an investment platform dedicated to providing investment insights and recommendations for retail investors in these regions, investing in Geron is now easier than ever. Through Zorion’s user-friendly platform, investors can access real-time data, market trends, and expert advice to help them make informed investment decisions. In addition, Zorion offers a wide range of educational materials and resources, empowering investors to enhance their investment knowledge and grow their portfolios. To invest in Geron as a retail investor from Malaysia, Thailand, Indonesia, or Vietnam, simply sign up on Zorion’s platform, complete the necessary documentation, and begin exploring the world of biopharmaceutical investing. With Zorion’s comprehensive support and resources, you can confidently navigate the stock market and potentially secure a promising future with Geron. Start investing in Geron today and make your mark in the dynamic field of biotechnology.
